Efficacy and safety of single-use suvorexant for insomnia during in-laboratory polysomnography in patients with obstructive sleep apnea: A feasibility study
T. Matsumura (Chiba, Japan), J. Terada (Chiba, Japan), T. Kinoshita (Chiba, Japan), Y. Sakurai (Chiba, Japan), M. Yahaba (Chiba, Japan), S. Sakao (Chiba, Japan), C. Yoshimura (Fukuoka, Japan), K. Tatsumi (Chiba, Japan)
Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Matsumura (Chiba, Japan), J. Terada (Chiba, Japan), T. Kinoshita (Chiba, Japan), Y. Sakurai (Chiba, Japan), M. Yahaba (Chiba, Japan), S. Sakao (Chiba, Japan), C. Yoshimura (Fukuoka, Japan), K. Tatsumi (Chiba, Japan). Efficacy and safety of single-use suvorexant for insomnia during in-laboratory polysomnography in patients with obstructive sleep apnea: A feasibility study. 2542
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: